Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA

Nucleic Acids Research

Volumn 31, Issue 21, 2003, Pages 6365-6372

  Frieden, Miriam ^a   Christensen, Signe M ^a   Mikkelsen, Nikolaj D ^a   Rosenbohm, Christoph ^a   Thrue, Charlotte A ^a   Westergaard, Majken ^a   Hansen, Henrik F ^a   Ørum, Henrik ^a   Koch, Troels ^a  

^a Santaris Pharma AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; EXONUCLEASE; NUCLEASE; NUCLEIC ACID; RIBONUCLEASE H;

ARTICLE; CHIMERA; CONTROLLED STUDY; DIASTEREOISOMER; DNA BASE COMPOSITION; DOWN REGULATION; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; GENE SEQUENCE; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOLECULAR STABILITY; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION;

ASPERGILLUS NUCLEASE S1; BASE SEQUENCE; DOWN-REGULATION; EXONUCLEASES; GENETIC ENGINEERING; KINETICS; LUCIFERASES; MOLECULAR STRUCTURE; NUCLEIC ACID DENATURATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDES, ANTISENSE; RIBONUCLEASE H, CALF THYMUS; STEREOISOMERISM; TEMPERATURE;

EID: 0344011088     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg820     Document Type: Article

References (23)

1. Zamecnik, P.C. and Stephenson, M. (1978) Inhibition of Rous Sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl Acad. Sci. USA, 75, 280-284.
2. Uhlmann, E. and Peyman, A. (1990) Antisense oligonucleotides: A new therapeutic Principle. Chem. Rev., 90, 543-584.
3. Crooke, S.T. (1999) Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta, 1489, 31-44.
4. Woolf, T.M., Melton, D.A. and Jennings, C.G.B. (1992) Specificity of antisense oligonucleotides in vivo. Proc. Natl Acad. Sci. USA, 89, 7305-7309.
5. Cook, P.D. (1999) Making drugs out of oligonucleotides: a review and perspective. Nucl., 18, 1141-1162.
6. Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. and Freier, S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem., 268, 14514-14522.
7. Koshkin, A.A., Singh, S.K., Nielsen, P., Rajwanshi, V.K., Kumar, R., Meldgaard, M., Olsen, C.E. and Wengel, J. (1998) LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation and unprecedented nucleic acid recognition. Tetrahedron, 54, 3607-3630.
8. Singh, S.K., Nielsen, P., Koshkin, A.A. and Wengel, J. (1998) LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem. Commun., 455-456.
9. Obika, S., Nanbu, D., Hari, Y., Andoh, J., Morio, K., Doi, T. and Imanishi, T. (1998) Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O, 4′-C -methyleneribonucleosides. Tetrahedron Lett., 39, 5401-5404.
10. Petersen, M., Bondensgaard, K., Wengel, J. and Jacobsen, J.P. (2002) Locked Nucleic Acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J. Am. Chem. Soc., 124, 5974-5982.
11. Wengel, J. (2001) LNA (Locked Nucleic Acid). In Crooke, S.T. (ed.), Antisense Drug Technology; Principles, Strategies and Applications. Marcel Dekker, Inc., New York, Basle, pp. 339-357.
12. Kurreck, J., Wyszko, E., Gillen, C. and Erdmann, V.A. (2002) Design of antisense oligonucleotides stabilized by Locked Nucleic Acids. Nucleic Acids Res., 30, 1911-1918.
13. Rajwanshi, V.K., Håkansson, A.E., Sørensen, M.D., Pitsch, S., Singh, S.K., Kumar, R., Nielsen, P. and Wengel, J. (2000) The eight stereoisomers of LNA (Locked Nucleic Acid): A remarkable family of strong RNA binding molecules. Angew. Chem. Int. Ed. Engl., 39, 1656-1659.
14. Rajwanshi, V.K., Kumar, R., Kofod-Hansen, M. and Wengel, J. (1999) Synthesis and restricted furanose conformations of three novel bicyclic thymine nucleosides: a xylo-LNA nucleoside, a 3′-O, 5′-C-methylene linked nucleoside and a 2′-O, 5′-C-methylene-linked nucleoside. J. Chem Soc., Perkin Trans. 1, 1407-1414.
15. Rajwanshi, V.K., Håkansson, A.E., Dahl, B.M. and Wengel, J. (1999) LNA stereoisomers: xylo-LNA (β-D-xylo configured locked nucleic acid) and α-L-LNA (α-L-ribo configured locked nucleic acid). Chem. Commun., 1395-1396.
16. Petersen, M., Håkansson, A.E., Wengel, J. and Jacobsen, J.P. (2001) α-L-LNA (α-L-ribo configured Locked Nucleic Acid) recognition of RNA. A study by NMR spectroscopy and molecular dynamics simulations. J. Am. Chem. Soc., 123, 7431-7432.
17. Wengel, J., Petersen, M., Nielsen, K.E., Jensen, G.A., Håkansson, A.E., Kumar, R., Sorensen, M.D., Rajwanshi, V.K., Bryld, T. and Jacobsen, J.P. (2001) LNA (locked nucleic acid) and the diastereoisomeric α-L-LNA: conformational tuning and high-affinity recognition of DNA/RNA targets. Nucl. Nucl., 20, 389-396.
18. Sørensen, M.D., Kværnø, L., Bryld, T., Håkansson, A.E., Verbeure, B., Gaubert, G., Herdewijn, P. and Wengel, J. (2002) α-L-ribo configured Locked Nucleic Acid (α-L-LNA): Synthesis and properties. J. Am. Chem. Soc., 124, 2164-2176.
19. Nielsen, C.B., Singh, S.K., Wengel, J. and Jacobsen, J.P. (1999) The solution structure of a locked nucleic acid (LNA) hybridized to DNA. J. Biomol. Struct. Dyn., 17, 175-191.
20. Nielsen, K.E., Petersen, M., Håkansson, A.E., Wengel, J. and Jacobsen, J.P. (2002) α-L-LNA (α-L-ribo configured Locked Nucleic Acid) recognition of DNA: An NMR spectroscopic study. Chem. Eur. J., 8, 3001-3009.
21. Pedersen, D.S., Rosenbohm, C. and Koch, T. (2002) Preparation of LNA phosphoramidites. Synthesis, 802-808.
22. Morita, K., Hasegawa, C., Kaneko, M., Tsutsumi, S., Sone, J., Ishikawa, T., Imanishi, T. and Koizumi, M. (2002) 2′-O, 4′-C-Ethylene-bridged Nucleic Acids (ENA): Highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug. Bioorg. Med. Chem. Lett., 73-76.
23. Min, K., Viazovkina, E., Galarneau, A., Parniak, M.A. and Damha, M.J. (2002) Oligonucleotides comprised of alternating 2′-deoxy-2′-fluoro-β-D -arabinonucleosides and D-2′-deoxyribonucleosides (2′F-ANA/DNA 'altimers') induce efficient RNA cleavage mediated by RNase H. Bioorg. Med. Chem. Lett., 12, 2651-2654.